Proteomic approach to studying the cytotoxicity of YC-1 on U937 leukemia cells and antileukemia activity in orthotopic model of leukemia mice

Proteomics

Volumn 7, Issue 18, 2007, Pages 3305-3317

  Chung, Jing Gung ^a   Yang, Jai Sing ^a   Huang, Li Jiau ^a   Lee, Fang Yu ^b   Teng, Che Ming ^c   Tsai, Sheng Chung ^a   Lin, Kuei Li ^d   Wang, Shu Fang ^a   Kuo, Sheng Chu ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b Yung Shin Pharmaceutical Industry Co Ltd   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

2 D PAGE; Apoptosis; Leukemia; Signal transduction

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL INFILTRATION; CELL STRAIN U937; CELL VIABILITY; CYTOTOXICITY; DOSE RESPONSE; ENZYME ACTIVATION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO CULTURE; LEUKEMIA; LEUKEMIA CELL; LYMPH NODE; MALE; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; SPLEEN CELL; SURVIVAL RATE; WEIGHT REDUCTION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; ELECTROPHORESIS, AGAR GEL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INDAZOLES; LEUKEMIA, EXPERIMENTAL; MALE; MASS SPECTROMETRY; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; U937 CELLS;

MUS;

EID: 34948817308     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200700200     Document Type: Article

References (39)

1. Lee, F. Y., Lien, J. C., Huang, L. J., Huang, T. M. et al., J. Med. Chem. 2001, 44, 3746-3749.
2. Wu, C. C., Ko, F. N., Kuo, S. C., Lee, F. Y., Teng, C. M., Br. J. Pharmacol. 1995, 116, 1973-1978.
3. Becker, E. M., Alonso-Alija, C., Apeler, H., Gerzer, R. et al., BMC Pharmacol. 2001, 1, 1-13.
4. Yeo, E. J., Chun, Y. S., Park, J. W., Biochem. Pharmacol. 2004, 68, 1061-1069.
5. Wang, S. W., Pan, S. L., Guh, J. H., Chen, H. L. et al., J. Pharmacol. Exp. Ther. 2005, 312, 917-925.
6. Xu, P. Q., Gong, J. P., Ai Zheng 2004, 23, 118-123.
7. He, Q., Na, X., Leuk. Res. 2001, 25, 455-461.
8. Yang, J. S., Kok, L. F., Lin, Y. H., Kuo, T. C. et al., Anticancer Res. 2006, 26, 219-225.
9. Durrant, L. G., Harding, S. J., Green, N. H., Buckberry, L D., Parsons, T., Cancer Res. 2006, 66, 5901-5909.
10. Modjtahedi, N., Giordanetto, F., Madeo, F., Kroemer, G., Trends Cell Biol. 2006, 16, 264-272.
11. Christophe, M., Nicolas, S., Curr. Pharm. Des. 2006, 12, 739-757.
12. [121 Katoh, M., Katoh, M., Technol. Cancer Res. Treat. 2006, 5, 169-175.
13. Yang, J. S., Hour, M. J., Kuo, S. C., Hung, L. J., Lee, M. R., Anticancer Res. 2004, 24, 1769-1778.
14. Hara, A., Niwa, M., Iwai, T., Nakashima, M. et al., Brain Res. Brain Res. Protoc. 1999, 4, 140-146.
15. Huang, W. W., Yang, J. S., Lin, C. F., Ho, W. J., Lee, M. R., Leuk. Res. 2005, 29, 685-692.
16. Kaji, H., Tsuji, T., Mawuenyega, K. G.., Wakamiya, A. et al., Electrophoresis 2000, 21, 1755-1765.
17. Li, X., Marani, M., Mannucci, R., Kinsey, B. et al., Cancer Res. 2001, 61, 1699-1706.
18. Lin, H. L., Yang, J. S., Yang, J. H., Fan, S. S. et al., Neurochem. Res. 2006, 31, 383-393.
19. Lin, C. C., Kao, S. T., Chen, G. W., Ho, H. C., Chung, J. G., Anticancer Res. 2006, 26, 227-242.
20. Martin, M. C., Allan, L. A., Lickrish, M., Sampson, C. et al., J. Biol. Chem. 2005, 280, 15449-15455.
21. Chun, Y. S., Yeo, E. J., Choi, E., Teng, C. M. et al., Biochem. Pharmacol. 2001, 61, 947-954.
22. Yeo, E. J., Chun, Y. S., Cho, Y. S., Kim, J. et al., J. Natl. Cancer Inst. 2003, 95, 516-525.
23. Huang, Y. T., Pan, S. L., Guh, J. H., Chung, Y. L. et al., Mol. Cancer Ther. 2005, 4, 1628-1635.
24. Chun, Y. S., Yeo, E. J., Park, J. W., Cancer Lett. 2004, 207, 1-7.
25. Rice, P. L., Peters, S. L., Beard, K. S., Ahnen, D. J., Mol. Cancer Ther. 2006, 5, 746-754.
26. Pan, S. L., Guh, J. H., Peng, C. Y., Wang, S. W. et al., J. Pharmacol. Exp. Ther. 2005, 314, 35-42.
27. Mulsch, A., Bauersachs, J., Schafer, A., Stasch, J. P. et al., Br. J. Pharmacol. 1997, 120, 681-689.
28. Ferrero, R., Torres, M., Neuropharmacology 2001, 41, 895-906.
29. Healy, D. A., Daly, P. J., Docherty, N. G., Murphy, M. et al., J. Am. Soc. Nephrol. 2006, 17, 805-812.
30. Kaur, J., Kaur, J., Ralhan, R., Int. J. Cancer 2000, 85, 1-5.
31. Xu, L., Dayal, M., Ouyang, Y. B., Sun, Y. et al., Neurobiol. Aging 2006, 27, 562-569.
32. Okubo, A., Kinouchi, H., Owada, Y., Kunizuka, H. et al., Brain Res. Mol. Brain Res. 2000, 84, 127-134.
33. Samali, A., Cai, J., Zhivotovsky, B., Jones, D. P., Orrenius, S., EMBO J. 1999, 18, 2040-2048.
34. Shchepina, L. A., Pletjushkina, O. Y., Avetisyan, A. V., Bakeeve, L. E. et al., Oncogene 2002, 21, 8149-8157.
35. Venturelli, D., Martinez, R., Melotti, P., Casella, I. et al., Proc. Natl. Acad. Sci. USA 1995, 92, 7435-7439.
36. Modjtahedi, N., Giordanetto, F., Madeo, F., Kroemer, G. et al., Trends Cell Biol. 2006, 16, 264-272.
37. He, Q., Na, X., Leuk. Res. 2001, 25, 455-461.
38. Degos, L., Wang, Z. Y., Oncogene 2001, 20, 7140-7145.
39. Vaughan, M. R., Pippin, J. W., Griffin, S. V. et al., Kidney Int. 2005, 68, 133-144.